Bachem is a Swiss-based pharmaceutical manufacturer with over 50 years of experience specializing in synthetic peptides and oligonucleotides. With facilities across Europe, Asia, and the United States, the company provides comprehensive CDMO solutions from research and clinical development through commercial production. Bachem’s services include CMC process development, GMP manufacturing of oligonucleotide-based APIs (such as siRNA, ASOs, and aptamers), custom peptide synthesis, amino acid derivatives, analytical services, and production of generics and new chemical entities.